Philips’ (PHG) shares have gained 16.6% in the year-to-date period, outperforming the Zacks Medical sector’s growth of 5.3%. The company is benefiting from a strong Diagnosis & Treatment segment, driven by its Precision Diagnosis and Image-Guided Therapy businesses. Hence, the company is making concerted efforts to strengthen these businesses. In this regard, Philips’ recent launch of the Duo Venous Stent System in a bid to boost its Image-Guided Therapy portfolio remains noteworthy. The Duo Venous Stent Sy ...